N-[5-[(3-acetylphenyl)carbamoylamino]-2-methylphenyl]acetamide | 1374006-35-5

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: N-[5-[(3-acetylphenyl)carbamoylamino]-2-methylphenyl]acetamide
• CAS: 1374006-35-5
• 化学式: C₁₈H₁₉N₃O₃
• 分子量: 325.367
• InChiKey: VKUBCEPFFKFUQB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  87.3
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-氨基-4-硝基甲苯 在 palladium on activated charcoal 、 氢气 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 9.0h， 生成 N-[5-[(3-acetylphenyl)carbamoylamino]-2-methylphenyl]acetamide
  参考文献：
  名称：

  New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: Design, synthesis, and antiproliferative activity against melanoma cell line

  摘要：

  A series of new diarylurea and diarylamide derivatives possessing acet(benz)amidophenyl scaffold was synthesized. Their in vitro antiproliferative activity was tested against A375P human melanoma cell line. Compounds 1c,d and 2c,d showed the highest potencies with IC50 values in sub-micromolar scale. In addition, compounds 1b,e,l and 2e,l were more potent than Sorafenib but with IC50 values in micromolar range. Moreover, compound 2c was equipotent to Vemurafenib, and 2d showed higher potency than Vemurafenib against A375P. Molar refractometry calculation and ADME profiling of the highest potent four derivatives 1c,d and 2c,d are also reported. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.03.020

文献信息

• New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: Design, synthesis, and antiproliferative activity against melanoma cell line
  作者：Hee Jin Kim、Hye Jung Cho、Hwan Kim、Mohammed I. El-Gamal、Chang-Hyun Oh、So Ha Lee、Taebo Sim、Jung-Mi Hah、Kyung Ho Yoo

  DOI：10.1016/j.bmcl.2012.03.020

  日期：2012.5

  A series of new diarylurea and diarylamide derivatives possessing acet(benz)amidophenyl scaffold was synthesized. Their in vitro antiproliferative activity was tested against A375P human melanoma cell line. Compounds 1c,d and 2c,d showed the highest potencies with IC50 values in sub-micromolar scale. In addition, compounds 1b,e,l and 2e,l were more potent than Sorafenib but with IC50 values in micromolar range. Moreover, compound 2c was equipotent to Vemurafenib, and 2d showed higher potency than Vemurafenib against A375P. Molar refractometry calculation and ADME profiling of the highest potent four derivatives 1c,d and 2c,d are also reported. (C) 2012 Elsevier Ltd. All rights reserved.